We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Custom Designed Microarrays Give Genomics Researchers Greater Flexibility

By LabMedica International staff writers
Posted on 02 Jun 2011
Genomics researchers can now order custom designed microarray plates that will allow them to evaluate samples with from 1,500 to 2.6 million markers.

The new Axiom myDesign Targeted Genotyping (TG) Arrays are a product of Affymetrix, Inc. More...
(Santa Clara, CA, USA). While Affymetrix encourages investigators to submit markers, many will prefer to depend on the well-characterized markers available in the Axiom Genomic Data Base.

The Axiom Genomic Database, with 11 million rare and common variants with minor allele frequency (MAF) greater than 1%, is derived from sources such as NHGRI, the International HapMap, and 1000 Genomes Project. Each marker is annotated by MAF, linkage disequilibrium (LD), and haplotype information, as well as SNP (single nucleotide polymorphism) classification and biological function. The database also contains approximately four million SNPs associated with key processes or pathways important to the study of pharmacogenomics genes, cardiovascular disease, the human leukocyte antigen (HLA) region, and inflammatory and immunity disease, as well as genes from the Sanger Cancer Gene Census and previous association studies.

Affymetrix has rendered the custom design process much simpler by creating the Axiom Design Center, an easy-to-use, web-based tool in that enables the researcher to quickly select markers from the Axiom Genomic Database and design the custom array. The Axiom Design Center provides access to markers based on gene symbol, chromosome, region, locus ID, biological category, or from previous commercial microarrays, including Affymetrix and others.

"Axiom myDesign TG Arrays will help researchers to quickly evaluate interesting variants from their GWAS (genome wide association study), sequencing, and candidate gene initiatives without limiting the number of markers in their study," said Andy Last, Chief Commercial Officer of Affymetrix. "Customers who want to add newly discovered content after they complete the initial design can benefit from our new flexible content capability without switching platforms."

Related Links:

Affymetrix, Inc.




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.